| 05.06 16:11 | dpa-AFX: *ALPHABET APPOINTS LILLY EXECUTIVE ANAT ASHKENAZI AS CFO |
| 05.06 14:44 | dpa-AFX: Eli-Lilly-Managerin wird Finanzchefin bei Google-Mutter Alphabet |
| 05.06 14:44 | Eli-Lilly-Managerin wird Finanzchefin bei Google-Mutter Alphabet |
| 05.06 14:39 | dpa-AFX: Eli-Lilly-Managerin wird Finanzchefin bei Google-Mutter Alphabet |
| 05.06 14:12 | dpa-AFX: Eli Lilly CFO Anat Ashkenazi Resigns |
| 05.06 13:50 | dpa-AFX: *ELI LILLY AND CO. CFO ANAT ASHKENAZI RESIGNS |
| 04.06 15:02 | dpa-AFX: *LILLY SAYS MELISSA SEYMOUR WILL JOIN COMPANY AS EVP OF GLOBAL QUALITY, EFFECTIVE JULY 22 |
| 01.06 15:53 | dpa-AFX: Lilly Announces Updated Data From Phase 1/2 Study Of Olomorasib In Advanced Solid Tumors |
| 30.05 11:56 | dpa-AFX: Biotech Stocks Facing FDA Decision In June 2024 |
| 29.05 12:03 | dpa-AFX: *LILLY, UNICEF EXPAND SUPPORT TO HELP MILLIONS OF YOUNG PEOPLE AT RISK OF NONCOMMUNICABLE DISEASES |
| 24.05 16:06 | dpa-AFX: Lilly Increases Investment In Indiana-Based Unit To Enhance Production Of Zepbound, Mounjaro |
| 24.05 15:36 | dpa-AFX: *ELI LILLY INVESTS ADDITIONAL $1.2 BLN TO UPGRADE INDIANAPOLIS FACILITIES AND WISCONSIN MANUFACTURING SITE |
| 24.05 15:34 | dpa-AFX: *LILLY DOUBLES INVESTMENT IN LEBANON, INDIANA SITE WITH NEW $5.3 BLN COMMITMENT |
| 21.05 15:13 | dpa-AFX: Lilly Reports Positive Phase 3 Trial Results Of Mirikizumab In Crohn's Disease |
| 21.05 14:04 | dpa-AFX: *LILLY'S MIRIKIZUMAB SHOWS POSITIVE RESULTS: OVER HALF OF CROHN'S PATIENTS ACHIEVE REMISSION, EVEN AFTER BIOLOGIC FAILURE |
| 16.05 15:32 | dpa-AFX: Lilly Says Phase 3 Trials Of Once-weekly Insulin In Type 2 Diabetes Meets Primary Endpoint |
| 16.05 13:48 | dpa-AFX: *LILLY : PHASE 3 TRIALS OF ONCE-WEEKLY INSULIN IN TYPE 2 DIABETES MEETS PRIMARY ENDPOINT |
| 16.05 11:40 | dpa-AFX: ROUNDUP: Roche erreicht ersten Studienerfolg bei Fettleibigkeit - Aktie legt zu |
| 16.05 11:40 | ROUNDUP: Roche erreicht ersten Studienerfolg bei Fettleibigkeit - Aktie legt zu |
| 16.05 11:35 | dpa-AFX: ROUNDUP: Roche erreicht ersten Studienerfolg bei Fettleibigkeit - Aktie legt zu |
|
|
